Advances in Health and Disease. Volume 22

Lowell T. Duncan (Editor)

Series: Advances in Health and Disease
BISAC: MED000000

Clear

$250.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

This compilation opens with a contribution towards understanding the molecular mechanism of acetylcholinesterase enzyme inhibition activity and its modulation, which will lead to the development of better Alzheimer disease drugs.

Acetylcholinesterase enzyme inhibitors are drugs indicated for the treatment of disease, as well as several other important applications in medical treatments.

The authors review what is currently known about the effects of interleukin-6, a well-known inflammation mediator, on the respiratory system. Papers are presented showing a general worsening of respiratory mechanics parameters both in animal experimentation and in humans.

Advances in Health and Disease. Volume 22 also discusses Graves’ orbitopathy, known also as thyroid-associated ophthalmopathy, the most common and debilitating extrathyroid manifestation of Graves’ disease.

Additionally, the authors discuss diabetic nephropathyis, a major micro-vascular complication of diabetes mellitus known to be the leading cause of end-stage renal disease worldwide.

The clinical calculation, techniques of measurement and regulation of cardiac ejection fraction is examined. Cardiac ejection fraction is defined as the volume of blood that is ejected by the ventricle during each contraction.

The concluding study aims to study the socioeconomic conditions of Beedi rollers to assess the health disturbances acquired as occupational hazards. (Imprint: Nova Medicine and Health)

Preface

Chapter 1. Efficiency and Modulation of Anti-Acetylcholinesterase Activity: An In-Vitro Study on Selected FDA Approved Alzheimer Drugs
(Prayasee Baruah, Mullah Muhaiminul Islam, Kripamoy Aguan and Sivaprasad Mitra, Center for Advanced Studies, Department of Chemistry, North-Eastern Hill University, Shillong, India, and others)

Chapter 2. Acetylcholinesterase Inhibitors: Types, Side Effects and Clinical Use
(Mateus Aquino Gonçalves, Federal University of Lavras, Lavras, MG, Brazil)

Chapter 3. The Effects of Interleukin-6 on Respiratory Mechanics
(Alessandro Rubini, Department of Biomedical Sciences, Section Physiology, University of Padova, Padua, Italy)

Chapter 4. Graves’ Orbitopathy: From Pathogenesis to Modern Treatment
(Mira Siderova, MD, PhD, Medical University Varna, Varna, Bulgaria, and others)

Chapter 5. An Overview of Diabetic Nephropathy: Epidemiology, Pathophysiology, Screening, Diagnosis and Current Treatment Strategy
(Pawan Kumar Kare, PhD, Neerja Aggarwal, PhD, Tripti Saxena, PhD, Om Prakash Kalra, DM, Basu Dev Banerjee, PhD, and Ashok Kumar Tripathi, PhD, Department of Medical Biochemistry, Gandhi Medical College, Bhopal, India, and others)

Chapter 6. Cardiac Ejection Fraction
(Jared S. Micho, Muhammed Saad, MD, Muhammad T. Hassan and Timothy J. Vittorio, MD, American University of the Caribbean School of Medicine, Sint Maarten)

Chapter 7. A Study on Occupational Health Hazard among Women Beedi Workers
(M. Jahanara, Assistant Professor of Zoology, Osmania College, Kurnool, AP, India)

Index

You have not viewed any product yet.


SHOW ALL OF MY RECENTLY VIEWED BOOKS